Harvard Testosterone Therapy and Sexual Dysfunction 2025

Testosterone therapy is one of the most controversial topics in medicine, yet multiple medical societies endorse its use, supported by level 1 evidence showing a variety of health benefits in men. This innovative and comprehensive course will focus on testosterone deficiency and its treatment in men and women and will also address several other sexual issues. Studies indicate that nearly 40% of men over the age of 45 have overtly low testosterone levels, yet education in this area is extremely limited. Similarly, there have been few educational opportunities to address sexual dysfunction in men and women. Approximately 40% of men and a similar percentage of women have one sexual dysfunction or another. Indeed, there have been several fascinating therapeutic advances in the treatment of sexual dysfunction in women that have received scant attention in other educational events.

The course is led by men’s health pioneer Abraham Morgentaler, MD, FACS whose research in the field transformed our understanding of the science of testosterone in men. Dr. Morgentaler has assembled as all-star faculty of thought leaders to address the most relevant issues and controversies, demystify the topic with science and clinical experience and provide an evidence-based approach to treatment. The course will also address management of several common sexual problems for men, including erectile dysfunction, and will also address several common sexual issues for women, including hypoactive sexual desire disorder. A clinical psychologist and sex therapist will explore non-medical strategies for managing couples with sexual complaints.